Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers

Open label and monocentric Phase I Clinical Trial, to Determine the Pharmacokinetics and Pharmacodynamics of Recombinant Human Erythropoietin for Subcutaneous Use in an Adult Male Population

Participants needed: 52
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: MegalabsUpdated: Aug 21, 2024Locations: 1
Eligibility criteria

Healthy eligible participants able to read, understand and sign the latest versi... [+5]

Present one or more flu-like symptoms such as: fever (body temperature greater t... [+15]

Read more
Status: Not yet recruiting

Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients

Phase III, multicentre, double-blind, randomised, parallel, equivalence clinical trial to determine the efficacy, safety and immunogenicity of Megalabs® recombinant human alfa epoetin for intravenous use, compared to Epogen®, in the treatment of anaemia in participants with chronic renal disease, dependent on haemodialysis

Participants needed: 280
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: MegalabsUpdated: Aug 19, 2024Locations: 1
Eligibility criteria

Stage V Chronic kidney disease undergoing hemodialysis

Lack of consent to participate in the trial, other severe chronic disease, histo...

Read more
Status: Not yet recruiting

Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

This study will compare the pharmacokinetics and pharmacodynamics, after single subcutaneous application, in healthy men, between filgrastim formulation, produced by Megalabs (test product) and Granulokine® (reference product) Amgen.

Participants needed: 100
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: MegalabsUpdated: Aug 16, 2024
Eligibility criteria

Healthy eligible participants able to read, understand and sign the latest versi... [+6]

Present one or more flu-like symptoms such as: fever (body temperature greater t... [+15]

Read more